Guiyang Xintian Pharmaceutical Co.,Ltd. (SHE:002873)

Market Cap	2.01B
Revenue (ttm)	873.38M
Net Income (ttm)	40.94M
Shares Out	231.28M
EPS (ttm)	0.18
PE Ratio	47.30
Forward PE	n/a
Dividend	0.08 (0.92%)
Ex-Dividend Date	Jan 20, 2025

Volume	2,316,412
Average Volume	4,703,248
Open	8.73
Previous Close	8.62
Day's Range	8.60 - 8.76
52-Week Range	7.41 - 12.65
Beta	0.07
RSI	44.51
Earnings Date	Apr 25, 2025

About SHE:002873

Guiyang Xintian Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of new Chinese patent medicines in China. The company offers products in various dosage forms, including hard capsules, mixtures, granules, gels, tablets, syrups, wines, dews, etc. Its products are used for the treatment of anti-tumor, gynecological, urological system diseases, oral, breast and thyroid, anti-cold, heat clearing, blood tonic, and cardiovascular diseases. Guiyang Xintian Pharmaceutical Co.,Ltd. was founded in 1995 and is based in...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1995
• Employees: 1,958
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002873

Financial Performance

In 2024, SHE:002873's revenue was 857.55 million, a decrease of -10.11% compared to the previous year's 953.98 million. Earnings were 52.32 million, a decrease of -35.30%.